Valuation: DarioHealth Corp.

Market Cap 36.94M 32.99M 30.48M 27.62M 51.67M 3.51B 52.53M 367M 145M 1.84B 139M 136M 5.79B P/E 2026 *
-0.94x
P/E 2027 * -1.67x
Enterprise Value 36.94M 32.99M 30.48M 27.62M 51.67M 3.51B 52.53M 367M 145M 1.84B 139M 136M 5.79B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.22x
Free-Float
78.35%
Yield 2026 *
-
Yield 2027 * -
1 day+10.56%
1 week-21.78%
Current month-43.05%
1 month-44.31%
3 months-51.60%
6 months-49.12%
Current year-66.87%
1 week 3.01
Extreme 3.01
5.32
1 month 3.01
Extreme 3.01
6.91
Current year 3.01
Extreme 3.01
13.64
1 year 3.01
Extreme 3.01
16.44
3 years 3.01
Extreme 3.01
52
5 years 3.01
Extreme 3.01
387.8
10 years 3.01
Extreme 3.01
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 2011-08-10
Chief Executive Officer 52 2013-08-08
Director of Finance/CFO 38 2020-12-31
Director TitleAgeSince
Chairman 52 2014-11-22
Director/Board Member 68 2013-11-11
Director/Board Member 57 2014-11-22
Date Insider Type Main position Quantity % Market Cap. Importance
9/24/26 Free

Chairman

54,000 0.5510%
9/24/26 Free

Director

61,000 0.6225%
9/24/26 Free

Director

28,000 0.2857%
Change 5-day change 1-year change 3-year change Capi.($)
+10.56%-21.78%-76.71%-90.85% 36.94M
+1.16%-1.13%-18.25%+9.38% 179B
+0.02%+4.24%-19.55%+15.88% 118B
-1.22%+0.70%+1.86%+32.59% 117B
+2.29%+17.36%-42.18%+8.22% 93.26B
-2.21%-2.91%-0.51%+75.12% 63.16B
-1.06%+1.75%+13.48%+74.12% 55.68B
-0.75%+3.73%+7.04%-23.26% 54.18B
-1.13%+0.00%-12.56%+30.09% 44.15B
+0.17%+5.85%-5.20%-11.43% 33.95B
Average +0.78%+1.06%-15.26%+11.98% 75.85B
Weighted average by Cap. -0.00%+3.09%-11.77%+21.98%

Financials

2026 *2027 *
Net sales 21.88M 19.54M 18.05M 16.36M 30.61M 2.08B 31.11M 217M 86.01M 1.09B 82.12M 80.38M 3.43B 30.37M 27.12M 25.05M 22.7M 42.47M 2.88B 43.18M 301M 119M 1.51B 114M 112M 4.76B
Net income -32.62M -29.13M -26.91M -24.39M -45.63M -3.1B -46.38M -324M -128M -1.62B -122M -120M -5.12B -21.4M -19.11M -17.65M -16M -29.93M -2.03B -30.42M -212M -84.09M -1.06B -80.3M -78.59M -3.35B
Net Debt - -
Projected Income Statement - Annual - DarioHealth Corp.
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
26-10-23 US$3.770 +10.56% 85,438
26-10-22 US$3.410 -7.34% 198,424
26-10-21 US$3.680 -9.80% 266,182
26-10-20 US$4.080 -9.13% 132,919
26-10-19 US$4.490 -6.85% 31,034
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DarioHealth Corp.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.770USD
Average target price
13.60USD
Spread / Average Target
+260.74%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DarioHealth Corp.
  1. Stock Market
  2. Stocks
  3. DRIO Stock